concentrex® 40mg tableta recubierta
instituto quimioterapico s.a. - tableta recubierta - por vial - atomoxetina
concentrex 25 mg tableta recubierta
instituto quimioterapico s.a. - tableta recubierta - por tableta - atomoxetina
concentrex® 60 mg tableta recubierta
instituto quimioterapico s.a. - tableta recubierta - por tableta - atomoxetina
concentre couleur lancome, delineador profesional con pincel
l'oreal chile s.a. - sin formulas
concentre moment jeunesse, infini jeunesse/anesi
bellimage s.a. - sin formulas
concentre rebellion age - "anesi" infini jeunesse - ampollas concetradas
bellimage s.a. - sin formulas
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasmas estomacales - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.